Evaluation of anticonvulsant drugs for soman-induced seizure activity

Journal of the American College of Toxicology

Volumn 15, Issue SUPPL. 2, 1996, Pages

  Shih, Tsung Ming ^a,b   McDonough Jr , John H ^a,b   Koplovitz, Irwin ^a,b  

^a Pharmacology Division   (United States)

^b US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

Author keywords

anticholinergic drugs benzodiazepines; Anti; Anticonvulsants; Convulsions; Eeg activity; Epileptic drugs; Excitatory amino acid antagonists; Excitotoxicity; Nerve agents; Neuropathology; Nmda receptors; Organophosphorus compounds; Seizures; Soman sarin vx

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; ANTICOAGULANT AGENT; ATROPINE; ATROPINE METHYL NITRATE; AZAPROPHEN; BENACTYZINE; BENZODIAZEPINE DERIVATIVE; BIPERIDEN; CARAMIPHEN; CARBAMAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DEXETIMIDE; DIAZEPAM; FELBAMATE; KETAMINE; LAMOTRIGINE; MAGNESIUM SULFATE; MEMANTINE; MIDAZOLAM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NERVE GAS; PENTOBARBITAL; PHENYTOIN; PROCYCLIDINE; SCOPOLAMINE; SOMAN; TIAGABINE; TRIHEXYPHENIDYL; UNINDEXED DRUG;

ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ANTICONVULSANT THERAPY; ARTICLE; CHEMICAL WARFARE; CONTROLLED STUDY; DRUG EFFICACY; ELECTROENCEPHALOGRAM; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SEIZURE;

EID: 0030480410     PISSN: 07300913     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Anderson DR, Gennings C, Carter WH, et al. (1994a) Efficacy comparison of scopolamine and diazepam against soman-induced debilitation in guinea pigs. Fundam Appl Toxicol 22:588-593.
2. Anderson DR, Harris LW, Bowersox SL, Lennox WJ, Anders JC. (1994b) Efficacy of injectable anticholinergic drugs against soman-induced convulsive/subconvulsive activity. Drug Chem Toxicol 17:139-48.
3. Berry W, Davis DR. (1970) The use of carbamates and atropine in protection of animals against poisoning by 1,2,2-trimethyIpropyl methylphosphonofluoridate. Biochem Pharmacol 19:927-34.
4. Bliss CI. (1952) The statistics of bioassay with special reference to the vitamins. In: Vitamin Methods, vol II. New York: Academic Press.
5. Bormann J. (1989) Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels. Ear J Pharmacol 166:591-592.
6. Boskovic B. (1981) The treatment of soman poisoning and its perspectives. Fundam Appl Toxicol 1:203-13.
7. Buccafusco JJ, Graham JH, VanLingen J, Aronstam RS. (1989) Protection afforded by clonidine from the acute and chronic behavioral toxicity produced by the cholinesterase inhibitor soman. Neurotoxicol Teratol 11:39-44.
8. Capacio BR, Shih T-M. (1991) Anticonvulsant actions of anticholinergic drugs in soman poisoning. Epilepsia 32:604-15.
9. Clement JG, Broxup B. (1993) Efficacy of diazepam and avizafone against soman-induced neuropathology in brain of rats. Neurotoxicol 14:485-504.
10. Dirnhuber P, French MC, Green DM, Leadbeater L, Stratton JA. (1979) The protection of primates against soman poisoning by pretreatment with pyridostigmine. J Pharm Pharmacol 31:295-9.
11. Dixon WJ, Massey FJ. (1981) Introduction to Statistical Analysis. New York: McGraw-Hill, 426-41.
12. Dunn MA, Sidell FR. (1989) Progress in medical defense against nerve agents. JAMA 262:649-52.
13. Gordon JJ, Leadbeater L, Maidment MP. (1978) The protection of animals against organophosphate poisoning by pretreatment with a carbamate. Toxicol Appl Pharmacol 43:207-16.
14. Harris LW, Gennings C, Carter WH, et al. (1994) Efficacy comparison of scopolamine (SCP) and diazepam (DZ) against soman-induced lethality in guinea pigs. Drug Chem Toxicol 17:35-50.
15. Hayward IJ, Wall HG, Jaax NK, Wade JV, Marlow DD, Nold JB. (1990) Decreased brain pathology in organophosphate-exposed rhesus monkeys following benzodiazepine therapy. J Neural Sei 98:99-106.
16. Johnson DD, Lowndes HE. (1974) Reduction by diazepam of repetitive electrical activity and toxicity resulting from soman. Eur J Pharmacol 28:245-50.
17. Johnson DD, Wilcox WC. (1975) Studies on the mechanism of the protective and antidotal actions of diazepam in organophosphate poisoning. Eur J Pharmacol 34:127-32.
18. Kluwe WM, Chinn JW, Feder JW, Olson C, Joiner R. (1987) Efficacy of pyridostigmine pretreatment against acute soman intoxication in a primate model. Proceedings of the Sixth Medical Chemical Defense Bioscience Review, Aberdeen Proving Ground, MD, AD No. B121516, 227-34.
19. Lallement G, Carpentier P, Collet A, Baubichon D, Pemot-Marino I, Blanchet G. (1992) Extracellular acetylcholine changes in rat limbic structures during soman-induced seizures. Neurotoxicology 13:557-68.
20. Lallement G, Delamanche IS, Pernot-Marino I, et al. (1993) Neuroprotective activity of glutamate receptor antagonists against soman-induced hippocampal damage: quantification with an w3 site ligand. Brain Res 618:227-37.
21. Lallement G, Pemot-Marino I, Baubichon D, Burckhart M-F, Carpentier P, Blanchet G. (1994a) Modulation of soman-induced neuropathology with an anticonvulsant regimen. Neuroreport 5:2265-8.
22. Lallement G, Pemot-Marino I, Foquin-Tarricone A, et al. (1994b) Antiepileptic effects of NBQX against soman-induced seizures. Neuroreport 5:425-8.
23. Lallement G, Pernot-Marino I, Foquin-Tarricone A, et al. (1994c) Coadministration of atropine, NBQX and TCP against soman-induced seizures. Neuroreport 5:1113-7.
24. Leadbeater L, Inns RH, Rylands JM. (1985) Treatment of poisoning by soman. Fundam Appl Toxicol 5:5225-31.
25. Lemercier G, Carpentier P, Sentenac-Roumanou H, Moralis P. (1983) Histological and histochemical changes in the central nervous system of the rat poisoned by an irreversible anticholinesterase organophosphorus compound. Acta Neuropathol (Berl) 61:123-9.
26. Lennox WJ, Harris LW, Talbot BG, Anderson DR. (1985) Relationship between reversible acetylcholinesterase inhibition and efficacy against soman lethality. Life Sei 37:793-8.
27. Lipp JA. (1968) Cerebral electrical activity following soman administration. Arch Int Pharmacodyn Ther 175:161-9.
28. Lipp JA. (1972) Effect of diazepam upon soman-induced seizure activity and convulsions. Electroencephalogr Clin Neurophysiol 32:557-60.
29. Lipp JA. (1973) Effect of benzodiazepine derivatives on soman-induced seizure activity and convulsions in the monkey. Arch Int Pharmacodyn Ther 202:244-51.
30. Martin LJ, Doebler JA, Shih T-M, Anthony A. (1985) Protective effect of diazepam pretreatment on somaninduced brain lesion formation. Brain Res 325:287-9.
31. McDonough JH, Jaax NK, Crowley RA, Mays MZ, Modrow HE. (1989) Atropine and/or diazepam therapy protects against soman-induced neural and cardiac pathology. Fundam Appl Toxicol 13:256-76.
32. McDonough JH, McLeod CG, Nipwoda MT. (1987) Direct micro-injection of soman or VX into the amygdala produces repetitive limbic convulsions and neuropathology. Brain Res 435:123-37.
33. McDonough JH, Shih T-M. (1993) Pharmacological modulation of soman-induced seizures. Neurosci Biobehav Rev 17:203-15.
34. McDonough JH, Shih T-M. ( 1995) A study of the W-methyl-d-aspartate antagonistic properties of anticholinergic drugs. Pharmacol Biochem Behav 51:249-53.
35. McLean MJ, Gupta RC, Dettbarn W-D, Wamil AW. (1992) Prophylactic and therapeutic efficacy of memantine against seizures produced by soman in the rat. Toxicol Appl Pharmacol 112:95-103.
36. McLeod CG. (1985) Pathology of nerve agents: perspectives on medical management. Fundam Appl Toxicol 5:510-6.
37. McLeod CG, Singer AW, Harrington DG. (1984). Acute neuropathology in soman poisoned rats. Neurotoxicology 5:53-8.
38. Moore DH, Clifford CB, Crawford IT, Cole GM, Baggett JM. (1995) Review of nerve agent inhibitors and reactivators of acetylcholinesterase. In: DM Quinn, AS Balasubramanian, BP Doctor, P Taylor, eds. Enzymes of the Cholinesterase Family. New York: Plenum Press, 297-304.
39. Petras JM. (1981) Soman neurotoxicity. Fundam Appl Toxicol 1:242.
40. Petras JM. ( 1994) Neurology and neuropathology of soman-induced brain injury: an overview. J Exp Anal Behav 61:319-29.
41. Philippens IHCHM, Melchers BPC, DeGroot DMG, Wolthius OL. (1992) Behavioral performance, brain histology, and EEG sequela after immediate combined atropine/diazepam treatment of soman-intoxicated rats. Pharmacol Biochem Behav 42:711-9.
42. Rump S, Grudzinska E, Edelwein Z. (1972) Effects of diazepam on abnormalities of bioelectrical activity of the rabbit's brain due to fluostigmine. Acta Nervoitsa Superior (Prague) 14:176-7.
43. Rump S, Grudzinska E, Edelwein Z. (1973) Effects of diazepam on epileptiform patterns of bioelectrical activity of the rabbit's brain induced by fluostigmine. Neuropharmacol 12:813-7.
44. Shih T-M. (1990) Anticonvulsant effects of diazepam and MK-801 in soman poisoning. Epilepsy Res 7:105-16.
45. Shih T-M, Koviak TA, Capacio BR. (1991) Anticonvulsants for poisoning by the organophosphorus compound soman: pharmacological mechanisms. Neurosci Biobehav Rev 15:349-62.
46. Shih T-M, McDonough JH. (1994) Neurochemical mechanisms and pharmacological control of soman-induced seizures and pathology. Can J Physiol Pharmacol 72(suppl. 1):396.
47. Smith SE, Durmuller N, Meldrum BS. (1991) The non-N-methyl-D-aspartate receptor antagonists, GYKI52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy. Ear J Pharmacol 201:179-83.
48. Sparenborg S, Brennecke LH, Beers ET. (1993) Pharmacological dissociation of the motor and electrical aspects of convulsive status epilepticus induced by the Cholinesterase inhibitor soman. Epilepsy Res 14:95-103.
49. Suzdak PD, Jansen JA. (1995) A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor. Epilepsia 36:612-26.
50. Taylor P. (1985) Anticholinesterase agents. In: Gilman AG, Goodman LS, Rail TW, Murad F. eds. The Pharmacological Basis of Therapeutics, 6th ed. New York: Macmillan, 110-29.
51. Vale JA, Scott GW. (1974) Organophosphorus poisoning. Guy's Hasp Rep 123:13-25.
52. Wills JH. (1963) Pharmacological antagonists of the anticholinesterase agents. In: Koelle GB, ed. Cholinesterases and anticholinesterase agents. Handbuch der Experimentellen Pharmakologie. Berlin: Springer-Verlag; 883-920.